1Weyer C, Tataranni P A, Bogardus C,et al. Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care.2001,24(1):89
2Weyer, Christian M D, Pratley, et al. Role of insulin resistance and insulin secretory dysfunction in the pathogenesis of type 2 diabetes mellitus:lessons from cross-sectional, prospective, and longitudinal studies in Pima Indians. Current Opinion in Endo
3Gungor, Neslihan, Arslanian, et al. Pathophysiology of Type 2 Diabetes Mellitus in Children and Adolescents: Treatment Implications. Treatments in Endocrinology,2002,1:359
4Gerich, John E M D. Contributions insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clinic Proceedings,2003,78(4):447
5Kahn S E. The importance of [beta]-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab,2001,86(9):4047
6Bergman R N, Finegood D T, Kahn S E. The evolution of [beta]-cell dysfunction and insulin resistance in type 2 diabetes. European Journal of Clinical Investigation,2002,32(1):35
7Saltiel A R. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. cell, 2001, 104(4):517
8McIntyre E A, Waller M. Genetics of type 2 diabhetes and insulin resistance: knowledge from human studies. Clin Endocrinol, 2002, 57(2):303
9Mauvais-Jarvis, Franck, Kulkarni, et al. Knockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance. Clinical Endocrinology, 2002, 57(1):1
10Tsao T S, Lodish H F, Fruebis J. ACRP30, a new hormone controlling fat and glucose metabolism. Eur J Pharmacol, 2002, 440(2):213
